Research has shed light on how a new type of antibody treatment reactivates patients’ immune cells to fight ovarian cancer.

For more than 25 years, chemical and biomolecular engineer Denis Wirtz has pushed cancer research beyond flat cell cultures ...

For a long time, scientists thought this cancer came from the ovaries. But this new research, led by Professor Alexander ...

I don't want to be explaining to my daughters why we've still failed to make progress on gynaecological cancers, writes Elise ...

Several cancers, including ovarian, cervical, testicular, kidney, and lung, often present no early symptoms, leading to ...

The electronic health record (EHR)–based symptom inventory identified symptom prevalence and associated comorbidities, but no ...

Ovarian cancer, historically challenging to diagnose due to vague early symptoms, often reaches advanced stages before ...

An Aiims study suggests lymph node removal after chemotherapy may improve survival in advanced ovarian cancer patients, ...

"It feels like we have been massively let down,” said Lindsey Rice after her sister Rhian Butlin was diagnosed with stage 4 ...

Study reveals how a new IgE antibody therapy reactivates immune cells, offering a promising approach to fighting ovarian ...